Diversity in Clinical Trials Summit Underscores Need for Targeting More Broadly Representative Patient Populations
The Diversity in Clinical Trials Summit presented by Dynamic Global Events (“DGE”) in June is an unequaled venue for your team to establish strategies ensuring that a diversity of patient populations are represented in the testing of new drug products. A key element of conducting sound trials is ensuring that minority populations are included in the testing because they will comprise a portion of the affected patient profile, and may have unique responses to the trials. But historically, clinical trials have excluded and overlooked them. The Diversity in Clinical Trials Summit aims to re-center drug development around patient diversity in…